Lung cancer study tests best sequence for combo therapy
Disease control
Terminated
This early-phase study looked at the safety of giving radiation therapy either before or after an immunotherapy drug (pembrolizumab) in 13 people with advanced non-small cell lung cancer. The goal was to find the best order to reduce side effects and improve tumor shrinkage. The …
Phase: PHASE1 • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Disease control
Last updated May 17, 2026 05:51 UTC